$GEL

ALBERT CONRAD P sold (to issuer) $37K of GEL

ALBERT CONRAD P sold (to issuer) 2,500 shares of GENESIS ENERGY LP (GEL) at $14.77 on 2026-07-01.

Original reporting
SEC EDGAR · ALBERT CONRAD P
Published Jul 2, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEL
Neutral
medium confidence
Mentioned
$GEL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GELNeutralLow
01

Why it matters

The newest disclosed fact is the specific sale: 2,500 shares at $14.7700 on 2026-07-01, leaving 15,000 shares. No 10b5-1 plan is indicated.

02

Market read

This provides incremental insider-trading data for GEL but is unlikely to drive a major repricing given the small transaction size and issuer-sale code.

03

What to watch

The transaction code is “sale to issuer,” which often corresponds to issuer buyback mechanics; without context on the buyback program, directional inference is weak.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-02; transaction dated 2026-07-01.

Background

The filing is an SEC Form 4 insider transaction for Genesis Energy LP (GEL) by director Albert Conrad P.

Company-level read

Ticker impact

$GELNeutralMedium confidence
Context

Genesis Energy LP director Albert Conrad P sold 2,500 shares to the issuer at $14.7700 on 2026-07-01, per Form 4.

Expected impact

Minimal immediate price impact; watch for follow-on insider activity or unusual volume around future buyback/insider filings.

Evidence & confidence

Form 4 shows a small, director-level transaction (total ~$36.9k) and explicitly notes no pre-arranged 10b5-1 plan, but the transaction code indicates sale to issuer, which is often mechanical and not a strong directional catalyst.

Market effects

No sector read-through; this is a single-company insider transaction with small dollar value.

None indicated.

None indicated.

Counterpoint

Absence of a 10b5-1 plan could be interpreted as less “scheduled” selling, so some traders may treat it as a mild negative signal despite the small size.

Key entities

  • GENESIS ENERGY LP

    Subject of the Form 4 insider transaction; director sold shares to the issuer.

  • ALBERT CONRAD P

    Director who sold 2,500 shares to the issuer at $14.7700 per share.

Related articles

$GELMed

Genesis Energy Q2 Earnings Call Highlights

Genesis Energy (NYSE:GEL) said it reduced borrowings on its $900 million senior secured credit facility to zero and retired about $218 million of Series A preferred securities in 1H 2026. It issued $750 million 6.75% notes due 2034 and redeemed 7.75% notes due 2028, targeting ~$25 million lower annualized all-in cost of capital. Quarterly distribution rose to $0.20.

$GELMed

Genesis Energy (NYSE:GEL) Delivers Strong Q2 CY2026 Numbers

Genesis Energy (NYSE:GEL) reported Q2 2026 results. Revenue rose 41% year on year to $532 million, beating Wall Street estimates by 26.2%, and GAAP profit was $0.26 per share above consensus. The article also cites adjusted EBITDA margin of 32.2% and free cash flow margin averaging -2.8% over five years, with shares up 2.4% to $15.21 after the release.

$GELMedAI 8/10

GENESIS ENERGY LP (GEL): Results of Operations and Financial Condition

GENESIS ENERGY LP (GEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a90ex9918kearnings_q22026.htm EX-99.1 Document FOR IMMEDIATE RELEASE August 6, 2026 Genesis Energy, L.P. Reports Second Quarter 2026 Results HOUSTON – (BUSINESS WIRE) – Genesis Energy, L.P. (NYSE: GEL) today announced its second quarter results. We generated the followi

$GELMed

Nifty, Sensex Continue to Push Higher: Tuesday Market Report

Tuesday’s BSE saw 2,293 stocks rise, 1,967 fall and 169 unchanged (advance/decline 1.16). On NSE, 83 issues hit 52-week highs while 28 closed at 52-week lows; Nifty Metal, Auto and Pharma led losers, while Nifty IT, FMCG and Media led gainers. Key corporate moves: Sonata Software NCLT-approved merger; Zydus Lifesciences to buy Assertio at $23.50/share; HCLTech invests ₹1,427.25 crore in Sarvam AI.